clock menu more-arrow no yes mobile

Piecing together the lung cancer puzzle

How 40 years of research finally lead to a breakthrough treatment

This advertising content was produced in collaboration between Vox Creative and our sponsor, without involvement from Vox Media editorial staff.

Solving a puzzle can be tricky. So many pieces look the same, with similar shapes and colors. But each piece has its own unique design and place in the bigger picture. In the fight for patients living with lung cancer, one mutation has been one of the toughest puzzles to take on. Watch the video to learn more about the determination of Amgen researchers and their commitment to patients that led to a breakthrough targeted treatment for people living with KRAS G12C mutated non-small cell lung cancer.

Please see full LUMAKRAS™ Patient Information at

Advertiser Content From Amgen logo